NASDAQ
BDMD
Last Price
US $1.10
Valuation
Financial
Performance
Financial risk - Cash flow debt coverage.
Baird Medical Investment Holdings Limited cash flow to debt ratio of -6.96% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.
Financial stability - Healthy cash flow growth.
Baird Medical Investment Holdings Limited's free cash flow has increased -84.88% from $-9.17M last year to $-1.39M, signaling increasing performance
Financial risk - Healthy debt to equity ratio.
Baird Medical Investment Holdings Limited's debt to equity ratio is 0.62, which means that the company's assets are unhealthy financed, signaling financial risk. READ MORE: A ratio over 0.60 means the company finances its assets with debt, signaling financial risk. If ratio is negative, the company spent its own equity and risks bankruptcy
Financial risk - Healthy debt to equity ratio development.
Baird Medical Investment Holdings Limited's debt has increased relative to shareholder equity from 0.53 last year to 0.62 today, signaling weakened financials
Financial risk - Net debt/EBITDA.
Baird Medical Investment Holdings Limited has negative EBITDA, making leverage ratio unreliable
Financial risk - ICR.
Baird Medical Investment Holdings Limited's interest coverage ratio is -34.75, which means that the company struggles to meet interest obligations, signaling financial risk.
Financial risk - Profit margin growth.
Baird Medical Investment Holdings Limited's profit margin has decreased (-459.97%) in the last year from 33.62% to -121.04%, signaling decreasing performance
Financial stability - Short term assets vs short term liabilities.
Baird Medical Investment Holdings Limited's short-term assets of $54.97M exceed its short-term liabilities of $32.36M
Decreasing performance - ROA.
Baird Medical Investment Holdings Limited's return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization
Decreasing performance - Absolute return on equity.
Baird Medical Investment Holdings Limited's return on equity of -81.48%, is lower than 15.00%, indicating bad performance
Decreasing performance - Earnings quality.
Baird Medical Investment Holdings Limited's operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation
Increasing performance - Earnings stability.
Baird Medical Investment Holdings Limited had positive net income in 4.00 out of 5 years, indicating stable and consistent earnings
Decreasing performance - Free cash flow.
Baird Medical Investment Holdings Limited has negative free cash flow, indicating the company is burning cash rather than generating it
Decreasing performance - FCF yield.
Baird Medical Investment Holdings Limited has negative free cash flow, indicating cash burn
Decreasing performance - Healthy earnings growth.
Baird Medical Investment Holdings Limited's yearly earnings has decreased -319.04% since last year from $12.45M to $-27.28M, signaling decreasing performance
Decreasing performance - Healthy revenue growth.
Baird Medical Investment Holdings Limited's yearly revenue has decreased -39.15% since last year from $37.04M to $22.54M, signaling decreasing performance
Decreasing performance - ROIC.
ROIC -50.73% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.
Decreasing performance - 3-year revenue CAGR.
Baird Medical Investment Holdings Limited's 3-year revenue CAGR of -13.72% is negative, indicating declining revenue over the past 3 years
Increasing performance - Revenue consistency.
Baird Medical Investment Holdings Limited had revenue growth in 3.00 out of 5 years, indicating consistent revenue performance
Increasing performance - ROE consistency.
Baird Medical Investment Holdings Limited had positive ROE in 4.00 out of 5 years, indicating consistent and reliable returns on equity
Overvalued - DCF valuation.
Baird Medical Investment Holdings Limited has insufficient data to evaluate this check.
Overvalued - Earnings yield.
Baird Medical Investment Holdings Limited has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails
Overvalued - EBITDA valuation.
Baird Medical Investment Holdings Limited is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model
Overvalued - EV/EBITDA.
Baird Medical Investment Holdings Limited has negative or missing EBITDA, making EV/EBITDA ratio unreliable
Overvalued - PEG ratio value.
Baird Medical Investment Holdings Limited has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails
Undervalued - P/B ratio.
Baird Medical Investment Holdings Limited has a price-to-book ratio of 1.02x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value
Undervalued - P/S ratio.
Baird Medical Investment Holdings Limited has a price-to-sales ratio of 1.41x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue
Profit margin
Current Ratio
Capital Returns
-81.48%
Return on equity
ROIC: -50.73%
Valuation History
-1.3X
Price to Earnings
EV/EBITDA: -2.8X
Cash flow
Profit margin
-
(FY vs FY)
Cash flow Y/Y
-
(FY vs FY)
Fair Value
Market $1.10
330.91%
Default assumptions
Base valuations use default assumptions. Customize in the Valuator.